Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05256771

Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.

Safety and Efficacy of Electrical Muscle Stimulation Combined with 1064 Nm Diode Laser, Pulsed Electromagnetic Field (PEMF) and Vacuum Assisted Radio Frequency (RF) for Non-invasive Body Contouring and Fat Reduction.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Venus Concept · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Multi-center, three-arm, randomized, evaluator-blinded study of electrical muscle stimulation (EMS) and/or 1064 nm diode laser, pulsed electromagnetic field (PEMF) and vacuum assisted radio frequency (RF) using the Venus Bliss Max for fat reduction, body contouring and aesthetic improvement.

Detailed description

The study will enroll up to 60 male and female subjects, ≥ 18 years of age, requesting non-invasive electrical muscle stimulation (EMS) and/or lipolysis of the abdomen and flanks. Subjects will be randomized to one of three arms as per randomization scheme. This study will have 3 Arms at a ratio of 2:1:1 (A:B:C): Arm A: Full Treatment Arm (Laser + EMS + RF/PEMF) Arm B: EMS/RF Arm (EMS + RF/PEMF) Arm C: EMS Arm (EMS only) Arm A: Three (3) diode laser treatments treatments at days 0, 28 and 56 (±2 days). Subjects will also receive bi-weekly electrical muscle stimulation and pulsed electromagnetic fields (PEMF)/vacuum assisted radio frequency (RF) treatments at days 0, 14, 28, 42 and 56 (±2 days). Arm B: Subjects will receive bi-weekly electrical muscle stimulation and pulsed electromagnetic fields/vacuum assisted radio frequency treatments at days 0, 14, 28, 42 and 56 (±2 days). Arm C: Subjects will receive weekly electrical muscle stimulation treatments at days 0, 7, 14, 21, 28 and 35 (±2 days). Subjects in Arms A and B will be followed at 84 and 140 days (±7 days) after their last treatment. Subjects in Arm C will be followed at 63 and 119 days (±7 days) after their last treatment.

Conditions

Interventions

TypeNameDescription
DEVICEEMSAbdominal muscle stimulation using EMS
DEVICE1064 nm diode laserAdipose tissue heating using 1064 nm diode laser
DEVICERF/PEMFCollagen re-modelling and reduction in subcutaneous fat using RF/PEMF

Timeline

Start date
2021-11-01
Primary completion
2025-07-31
Completion
2025-09-30
First posted
2022-02-25
Last updated
2025-03-28

Locations

3 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05256771. Inclusion in this directory is not an endorsement.